Contract and clinical research organizations (CROs) in the Asia Pacific region are increasingly being leverage by the biopharmaceutical industry to counter challenges of recession, patent expiry, rising R&D costs and dwindling productivity.
Some survey findings:
24% CROs bet on quality of performance
30% say client expansion is of highest priority
55% function in reve ...
Satisfied Users & 
Approved Press Releases
